West Virginia Intellectual Property Cases

Patent Cases, Dockets and Filings
Cases filed
Cases 1 - 10 of 130
RSS Feed | View as table
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff: Regeneron Pharmaceuticals, Inc.
Counter Claimant: Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified: AFLIBERCEPT PATENT LITIGATION
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd.
as 1:2023cv00106
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Samsung Bioepis Co., Ltd.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as 1:2023cv00097
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Formycon AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2023cv00089
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff: Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant: Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. We have downloadable decisions or orders for this case
as 1:2022cv00061
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2022cv00035
Plaintiff: AstraZeneca AB and Astrazeneca Pharmaceuticals LP
Defendant: Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00023
Counter Defendant: Novo Nordisk, Inc. and Novo Nordisk, A/S
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?